In May, former President Joe Biden was diagnosed with metastatic prostate cancer. The announcement was made promptly and transparently, serving as a sobering reminder of how silently prostate cancer can progress—often without symptoms until it has spread. Even with access to world-class health care, his cancer was not detected early.
This high-profile case brought renewed attention to an urgent issue: Prostate cancer remains one of the most curable cancers when caught early, but a combination of outdated screening practices and age-based cutoffs continues to delay diagnosis for too many men.
